Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Mar 28, 2016
Kiran Mazumdar- Shaw speaking on Biocon’s landmark achievement of receiving Regulatory Approval for its first Insulin Glargine from PMDA, MHLW in Japan. Proud moment for Biocon, Endorsement of our Capability in Biosimilars and Commitment to Quality. First Biosimilar From India to be approved in Japan. Prefilled Pen to be launched in Q1 FY17.